The International Tinnitus Journal


rolex replica

replica watches
melbet güncel

The International Tinnitus Journal

Official Journal of the Neurootological and Equilibriometric Society
Official Journal of the Brazil Federal District Otorhinolaryngologist Society

*Type a word

ISSN: 0946-5448


Tinnitus Treatment with Misoprost: A Blinded and Placebo Controlled Study

Author(s): Anuradha Sharma, Jaimanti Bakshi, Sanjay Munjal

Introduction: The purpose of conducting research was to investigate the efficacy of the misoprost as a treatment modality for tinnitus.
Methodology: A sample of 130 subjects with hearing loss and tinnitus were randomly segregated into control (N=70) and misoprost group (N=60). Misoprost group were administered a dosage of 200 μg per day of misoprostol and it was increased to 1600 ug, for 3 months and Control group (70 subjects) received the 200 ug/day of placebo tablets. Pre and post assessment on audiological measures (tinnitus pitch and loudness matching), Tinnitus handicap inventory and Visual analogue scale was performed.
Results and Discussion: Statistically significant differences were observed between pre-and post-misoprost treatment in terms of tinnitus pitch and loudness (p<0.001) for misoprost group. On visual analogue scale 33.3% of misoprost group subjects reported improvement; also 50% of them reported reduction in scores of tinnitus handicap inventory post-treatment. The results suggest that misoprost might act as an effective treatment modality for alleviation of tinnitus; however larger randomized controlled clinical trials are required to support these findings.

Text PDF

Share this  Facebook  Twitter  LinkedIn  Google+